Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Flavanols, a subclass of flavonoids found in foods such as cocoa, tea, apples, and certain berries, have been studied for their potential anti-inflammatory and antioxidant effects in the context of Inflammatory Bowel Disorders (IBD), including Crohn’s disease and ulcerative colitis. Preclinical studies, primarily in animal models, suggest that flavanols can modulate inflammatory pathways, reduce oxidative stress, and help preserve intestinal barrier function. Some mechanisms proposed include the inhibition of NF-κB signaling, reduction of pro-inflammatory cytokine production, and enhancement of gut microbiota composition. Small human studies and pilot clinical trials are limited but have shown that flavanol-rich foods (like cocoa or green tea extracts) may modestly reduce some markers of inflammation and improve symptoms in IBD patients. However, these studies often have small sample sizes, short durations, and sometimes lack rigorous controls.

Current clinical evidence is insufficient to recommend flavanols as a standalone or primary therapy for IBD, but there is a scientific rationale for their supportive use as part of a broader dietary strategy. No major medical guidelines currently endorse flavanols specifically for IBD management. Therefore, the evidence rating is modest (2/5), reflecting preliminary but not definitive scientific support. More large-scale, well-designed human clinical trials are needed to confirm benefits and establish appropriate dosing and safety.

More about flavanols (various)
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by flavanols (various)

Products containing flavanols (various)